Tropical Journal of Pharmaceutical Research

Case Report | OPEN ACCESS

Pancytopenıa and Sepsıs due to Meropenem: A Case Report

Muzaffer Erden, Erim Gulcan , Arzu Bılen, Yusuf Bılen, Abdullah Uyanık, Mustafa Keles

Department of Internal Medicine, M.D. Ataturk University School of Medicine, Central Campus, Erzurum, Turkey;

For correspondence:- Erim Gulcan Email: drerimgulcan@gmail.com Tel:+905056887688

Received: 26 January 2012 Accepted: 29 November 2012 Published: 21 February 2013

Citation: Erden M, Gulcan E, Bılen A, Bılen Y, Uyanık A, Keles M. Pancytopenıa and Sepsıs due to Meropenem: A Case Report. Trop J Pharm Res 2013; 12(1):127-129 doi: 10.4314/tjpr.v12i1.21

© 2013 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Meropenem is one of the most commonly used antibacterial agents with relatively few side effects. Serious adverse reactions reported with meropenem are rare with an incidence of 1 %. Recently we came across two rare adverse effects of meropenem in one patient with acute renal failure. There was pancytopenia and sepsis, respectively. To the best of our knowledge, a only few cases have been reported in the literature that document an association between meropenem administration and pancytopenia, and about half of these cases were sepsis. With the use of meropenem becoming more widespread, these two rare but fatal complications of meropenem should be borne in mind.

Keywords: Meropenem, Pancytopenia, Sepsis, Fatal complications